Determination of the genome composition of influenza virus reassortants using multiplex reverse transcription-polymerase chain reaction followed by fluorescent single-strand conformation polymorphism analysis

Analytical Biochemistry

Volumn 252, Issue 1, 1997, Pages 24-32

  Cha, Tai An ^a   Zhao, Jackie ^a   Lane, Elizabeth ^a   Murray, Michael A ^a   Stec, David S ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS; FLUORESCENCE; OLIGONUCLEOTIDES; POLYMORPHISM; TRANSCRIPTION; VACCINES; VIRUSES;

ANNUAL PRODUCTION; COST-EFFECTIVE METHODS; GENOME COMPOSITION; INFLUENZA VACCINES; OLIGONUCLEOTIDE PRIMERS; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISMS (SSCP); SINGLE-STRAND CONFORMATION POLYMORPHISM;

POLYMERASE CHAIN REACTION;

FLUORESCENT DYE; INFLUENZA VACCINE; OLIGONUCLEOTIDE; VIRUS DNA; VIRUS RNA;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE; INFLUENZA VIRUS B; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; VIRUS GENOME; VIRUS STRAIN;

DNA VIRUSES; INFLUENZA VIRUS; INFLUENZAVIRUS B; RNA VIRUSES;

EID: 0031260556     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1997.2269     Document Type: Article

References (19)

1. Lamb R. A., Krug R. M. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 1353-1395.
2. Murphy B. R., Webster R. G. Fields B. N., Knipe D. M., Howley P. M. Fields Virology. 1996;1397-1445 Lippincott-Raven, Philadelphia.
3. Webster R. G., Bean W. J., Gorman O. T., Chambers T. M., Kawaoka Y. Microbiol. Rev. 56:1992;152-179.
4. Clements M. L. Ellis R. W. Vaccines: New Approaches to Immunological Problems. 1992;129-150 Butterworth-Heinemann, Boston.
5. Taubenberger J. K., Reid A. H., Krafft A. E., Bijwaard K. E., Fanning T. G. Science. 275:1997;1793-1796.
6. Scholtissek C. Palese P., Kingsbery D. W. Genetics of Influenza Viruses. 1984;99-126 Springer, Vienna.
7. Palese P., Schulman J. L. Proc. Natl. Acad. Sci. USA. 73:1976;2142-2146.
8. Ritchey M. B., Palese P., Schulman J. L. J. Viol. 20:1976;307-313.
9. Hay A. J., Bellamy A. R., Abraham G., Skehel J. J., Brand C. M., Webster R. G. Dev. Biol. Stand. 39:1977;15-24.
10. Ghendon Y. Z., Klimov A. I., Alexandrova G. I., Polezhaev F. I. J. Gen. Virol. 53:1981;215-224.
11. Sakamoto S., Kino Y., Oka T., Herlocher M. L., Maassab H. F. J. Virol. Methods. 56:1996;161-171.
12. Klimov A. I., Cox N. J. J. Virol. Methods. 52:1995;41-49.
13. Orita M., Suzuki Y., Sekiya T., Hayashi K. Genomics. 5:1989;874-879.
14. Maassab H. F., DeBorde D. C. Vaccine. 3:1985;355-369.
15. Dowdle W. R., Schild G. C. Kilbourne E. D. Laboratory Propagation of Human Influenza Viruses, Experimental Host Range, and Isolation from Clinical Material. 1975;243-268 Academic Press, Orlando.
16. Sarkar G., Yoon H.-S., Sommer S. S. Genomics. 13:1992;441-443.
17. Hayashi K. GATA. 9:1992;73-79.
18. DeBorde D. C., Donabedian A. M., Herlocher M. L., Naeve C. W., Maassab H. F. Virology. 163:1988;429-443.
19. Iwahana H., Yoshimoto K., Mizusawa N., Kudo E., Itakura M. Biotechniques. 16:1994;296-304.